Marco Moschini1, Giorgio Gandaglia2, Paolo Dell'Oglio2, Nicola Fossati2, Vito Cucchiara2, Giusy Burgio2, Agostino Mattei3, Rocco Damiano4, Shahrokh F Shariat5, Andrea Salonia2, Francesco Montorsi2, Alberto Briganti2, Renzo Colombo2, Andrea Gallina2. 1. Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy. Electronic address: marco.moschini87@gmail.com. 2. Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy. 3. Klinik für Urologie, Luzerner Kantosspital, Lucerne, Switzerland. 4. Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy. 5. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
Abstract
INTRODUCTION: Previous studies showed high hospital readmission rates after radical cystectomy (RC) for bladder cancer (BCa), however at the time results of a European series analyzing this event were still missing. PATIENTS AND METHODS: Overall, 1090 consecutive BCa patients treated with RC at a single center between January 2002 and August 2012 were identified. Logistic regression analyses were used to test the association between covariates and 30-day readmission in the overall population and after stratifying according age at the time of surgery. RESULTS: Mean length of stay (LOS) was 19 days (median, 16 days), and the overall 30-day readmission rate was 12.2%. The most frequent reasons for readmission at 30 days were ileus (n = 15; 11.3%), lymphoceles (n = 11; 8.3%), wound infection (n = 10; 7.5%), and fever (n = 12; 9.0%). In multivariable logistic regression analysis, age (odds ratio [OR], 1.02; P = .04) and LOS (OR, 0.94; P < .01) were associated with 30-day readmission. However, when analyzed according age at the time of surgery, a beneficial effect from a longer LOS was observed only in patients older than 70 years (P < .003). CONCLUSION: In the first European series on the effect of 30-day readmission, our data showed that even with a relative high mean LOS, 30-day readmission remained an ineradicable factor. Of note, older patients and shorter LOS were associated with an increased risk of readmission at 30 days, however, an increase of LOS to prevent readmission seemed effective only in patients older than 70 years.
INTRODUCTION: Previous studies showed high hospital readmission rates after radical cystectomy (RC) for bladder cancer (BCa), however at the time results of a European series analyzing this event were still missing. PATIENTS AND METHODS: Overall, 1090 consecutive BCa patients treated with RC at a single center between January 2002 and August 2012 were identified. Logistic regression analyses were used to test the association between covariates and 30-day readmission in the overall population and after stratifying according age at the time of surgery. RESULTS: Mean length of stay (LOS) was 19 days (median, 16 days), and the overall 30-day readmission rate was 12.2%. The most frequent reasons for readmission at 30 days were ileus (n = 15; 11.3%), lymphoceles (n = 11; 8.3%), wound infection (n = 10; 7.5%), and fever (n = 12; 9.0%). In multivariable logistic regression analysis, age (odds ratio [OR], 1.02; P = .04) and LOS (OR, 0.94; P < .01) were associated with 30-day readmission. However, when analyzed according age at the time of surgery, a beneficial effect from a longer LOS was observed only in patients older than 70 years (P < .003). CONCLUSION: In the first European series on the effect of 30-day readmission, our data showed that even with a relative high mean LOS, 30-day readmission remained an ineradicable factor. Of note, older patients and shorter LOS were associated with an increased risk of readmission at 30 days, however, an increase of LOS to prevent readmission seemed effective only in patients older than 70 years.
Authors: Ahmet Murat Aydin; Richard R Reich; Biwei Cao; Salim K Cheriyan; Ali Hajiran; Logan Zemp; Alice Yu; Michael A Poch; Wade J Sexton; Roger Li; Scott M Gilbert Journal: Urol Oncol Date: 2021-10-08 Impact factor: 3.498
Authors: Matthew S Lee; Brent K Hollenbeck; Mary K Oerline; Ted A Skolarus; Bruce L Jacobs; Rita Jen; Amy N Luckenbaugh; Vahakn Shahinian; Tudor Borza Journal: Urol Pract Date: 2018-10-07
Authors: Sophia Liff Maibom; Ulla Nordström Joensen; Alicia Martin Poulsen; Henrik Kehlet; Klaus Brasso; Martin Andreas Røder Journal: BMJ Open Date: 2021-04-14 Impact factor: 2.692